Rocuronium Bromide Injection, Solution
Product Images NDC 55150-225

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 55150-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Time To 80% Or Greater Block Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Fig1)

A scatter and box plot chart entitled "Time to 80% or Greater Block vs. Initial Dose of Rocuronium Bromide by Age Group" showing data grouped by age ranges 18 to 64 years, 65 years and older, and 1 to 12 years. The x-axis displays initial Rocuronium Bromide doses in mg/kg, ranging from 0.45 to 1.2. The y-axis shows time in minutes, from 0 to 9. The plot includes median, 25th and 75th percentiles, and individual data points for each dose and age group.*

FDA Label Image

Figure 2: Duration Of Clinical Effect Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Fig2)

A box plot chart titled 'Duration of Clinical Effect vs. Initial Dose of Rocuronium Bromide by Age Group.' It displays median, 25th and 75th percentiles, and individual values of duration in minutes on the y-axis against initial dose in mg/kg on the x-axis. Data are grouped by age categories: 18 to 64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years. Each age group has plotted data points showing variability in clinical effect duration with different doses.*

FDA Label Image

Figure 3: Duration Of Clinical Effect Vs. Number Of Rocuronium Bromide Maintenance Doses, By Dose (Rocuronium Fig3)

A line graph titled 'Duration of Clinical Effect vs. Number of Rocuronium Bromide Maintenance Doses, by Dose,' depicting the relationship between dose number (x-axis) and duration in minutes (y-axis). Two dose levels, 0.1 mg/kg and 0.15 mg/kg, are plotted with corresponding sample sizes (N=29 and N=13 respectively). Duration increases with dose number for both doses, with the higher dose showing longer duration.*

FDA Label Image

Package Label-principal Display Panel (50 mg per 5 mL (10 mg / mL))

Label for Rocuronium Bromide Injection, 50 mg per 5 mL (10 mg/mL), an intravenous solution in a multiple dose vial. The label includes warnings about its paralyzing effects and respiratory arrest, storage instructions to refrigerate between 2° to 8°C, and manufacturer information for AuroMedics Pharma LLC. The product is labeled for prescription use only by Eugia US LLC.*

FDA Label Image

Package Label-principal Display Panel (50 mg per 5 mL (10 mg / mL))

Carton packaging label for Rocuronium Bromide Injection, 50 mg per 5 mL (10 mg/mL), multiple dose vials. The label indicates sterile, nonpyrogenic solution for intravenous use only, distributed by AuroMedics Pharma LLC, made in India. The box contains 10 vials of 5 mL each. A warning states it is a paralyzing agent requiring artificial respiration facilities.*

FDA Label Image

Package Label-principal Display Panel (100 mg per 10 mL (10 mg / mL))

Rocuronium Bromide Injection 100 mg per 10 mL (10 mg/mL) label for intravenous use. The label indicates a 10 mL multiple dose vial, with warnings about the product being a paralyzing agent causing respiratory arrest. It is sterile, nonpyrogenic, and distributed by AuroMedics Pharma LLC. Storage instructions specify refrigeration at 2° to 8°C and usage guidelines after removal from refrigeration or opening.*

FDA Label Image

Package Label-principal Display Panel (100 mg per 10 mL (10 mg / mL))

Packaging label for Rocuronium Bromide Injection, 100 mg per 10 mL (10 mg/mL), multiple dose vials. The label indicates sterile, nonpyrogenic solution for intravenous use only, labeled as a prescription drug. Distributed by AuroMedics Pharma LLC, made in India. The label contains warnings about its paralyzing agent effects and storage instructions.*

FDA Label Image

Package Label-principal Display Panel (Peel-off Label)

A red label for Rocuronium Bromide Injection solution indicating 10 mg/mL concentration for intravenous use only. The label includes fields for Date, Time, and By for application to a syringe. It is marked Rx only and produced by Eugia US LLC.*

FDA Label Image

Rocuronium Bromide Chemical Structure (Rocuronium Str)

Chemical structure diagram of rocuronium bromide, showing the molecular arrangement of its atoms including rings, hydroxyl group, acetate group, and bromide ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.